Showing results (2231-2240 of 5,939) with videos related to
Sort By:
Pageof 594
The Prostate|October 7, 2004
Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancerAbhik Bandyopadhyay, Long Wang, Fernando López-Casillas, et al.The Prostate|October 7, 2004
Establishment and characterization of a human primary prostate carcinoma cell line, HH870Senthamil R Selvan, Andrew N Cornforth, Nagesh P Rao, et al.The Prostate|September 21, 2004
Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancerAnna J Lind, Pernilla Wikström, Torvald Granfors, et al.The Prostate|January 1, 1992
Blockade of the LH response induced by the agonist D-Trp-6-LHRH in rats by a highly potent LH-RH antagonist SB-75J Pinski, T Yano, G Miller, et al.The Prostate|September 21, 2004
Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanismRosa M Sainz, Juan C Mayo, Dun-xian Tan, et al.The Prostate|May 27, 2004
Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell linesAlvin Y Liu, Kristen D Brubaker, Young Ah Goo, et al.The Prostate|May 27, 2004
Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasiaDorit K Nägler, Sabine Krüger, Angela Kellner, et al.The Prostate|May 27, 2004
High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cellsNatsuki Takaha, Linda M S Resar, Don Vindivich, et al.The Prostate|April 1, 1994
Influence of culture media on the morphological differentiation of the PC-3 and DU145 prostatic neoplastic cell linesI Camby, C Etievant, M Petein, et al.The Prostate|January 1, 1993
Comparison of the pathologic features and DNA ploidy value of prostate cancers detectable by sonography and by palpationM Ohori, T M Wheeler, D R Greene, et al.Pageof 594